Case report: A case of pyoderma gangrenosum with intractable leg ulcers treated by allogeneic cultured dermal substitutes

Dermatology Online Journal

Volumn 14, Issue 11, 2008, Pages

  Toyozawa, Seiko ^a   Yamamoto, Yuki ^a   Nishide, Takeshi ^a   Kishioka, Akiko ^a   Kanazawa, Nobuo ^a   Matsumoto, Yasuhiro ^b   Kuroyanagi, Yoshimitsu ^b   Furukawa, Fukumi ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PREDNISOLONE; SODIUM CHLORIDE; IMMUNOSUPPRESSIVE AGENT;

AGED; ARTICLE; CASE REPORT; DEBRIDEMENT; DRUG DOSE REDUCTION; EPITHELIZATION; FEMALE; HUMAN; LEG ULCER; PSEUDOMONAS AERUGINOSA; PYODERMA GANGRENOSUM; RHEUMATOID ARTHRITIS; SKIN ALLOGRAFT; SKIN FIBROBLAST; WOUND DRESSING; ALLOTRANSPLANTATION; ARTIFICIAL SKIN; AUTOTRANSPLANTATION; CELL CULTURE; FIBROBLAST; IMMUNE DEFICIENCY; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; PSEUDOMONAS INFECTION; SKIN TRANSPLANTATION; SURGICAL SPONGE; TRANSPLANTATION; WOUND HEALING;

AGED; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; COMBINED MODALITY THERAPY; DEBRIDEMENT; FEMALE; FIBROBLASTS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; LEG ULCER; PREDNISOLONE; PSEUDOMONAS INFECTIONS; PYODERMA GANGRENOSUM; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL; SURGICAL SPONGES; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING;

EID: 57049146395     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Adam J, Richard AF. Cutaneous Wound Healing. New England J Med 1999 sep2;341(10):738-46. PubMed
2. Green H, Kehindez O, Thomas J, Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. Proc Natl Acad Sci USA 1979 Nov;76(11): 5665-8. PubMed
3. Bell E, Ehrlich HP, Sher S, Merrill C, Sarber R, Hull B, Nakatsuji T, Church D, Buttle DJ. Development and use of a living skin equivalent. Plast Reconstr Surg 1981 Mar;67(3):386-92. PubMed
4. Cooper ML, Hansbrough JF, Spielvogel RL, Cohen R, Bartel Rl, Naughton G. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polygractin mesh. Biomaterials 1991Mar;12 (2):243-48. PubMed
5. Hansbrough JF, Morgan J, Greenleaf G. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material. Surgery 1994 May;115(5):633-44. PubMed
6. Kuroyanagi Y, Kubo K, Matsui H et al. Establishment of banking system for allogeneic cultured dermal substitute. Artif Organs 2004 Jan;28(1):13-21. PubMed
7. Harima N, Asai S, Wako M, et al. Clinical trials using allogeneic cultured dermal substitutes for skin ulcers. Jpn J Dermatol 2003;113:253-64 (abstract in English)
8. Oka H, Fujitsu M, Suenobu K , et al. Clinical trials with allogeneic cultured dermal substitute(CDS) for the treatment of burns and skin ulcers. Jpn J Burn Injuries 2002;28:333-42 (abstract in English)
9. Robert KP, Vincent C. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996 Jun;34(6):1047-60. PubMed
10. Kubo K, Kuroyanagi Y. Spongy matrix of hyaluronic acid and collagen for cultured dermal substitute; evaluation in animal test. J Artif Organ 2003;6(1):64-70. PubMed
11. Kubo K, Kuroyanagi Y. Characterization of cultured dermal substitute composed of spongy matrix of hyaluronic acid and collagen combined with fibroblasts. J Artif Organ 2003;6(2):138-44. PubMed
12. Kubo K, Kuroyanagi Y. Development cultured dermal substitute composed of hyaluronic acid and collagen combined with fibroblasts; Fundamental evaluation. J Biomater Sci Polymer Edn 2003;14(7):625-41. PubMed
13. Ohtani T, Okamoto K, Kaminaka C, Kishi T, Sakurane M, Yamamoto Y, Uede K, Kubo K, Kuroyanagi Y, Furukawa F. Digital gangrene associated with idiopathic hypereosinophilia: treatment with allogeneic cultured dermal substitute (CDS). Eur J Dermatol 2004 May-Jun;14(3):168-71. PubMed
14. Kubo K, Kuroyanagi Y. Development of cultured dermal substitute composed of spongy matrix of hyaluronic acid and atelocollagen combined with fibroblasts; cryopreservation. Artif Organs 2004 Feb;28(2):182-8. PubMed
15. Brunsting LA, Goecker WH, O'Leary PA. Pyoderma(ecthyma) gangrenosum: clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930;22:655-80
16. Trevor Brooklyn, Giles Dunnill, Chris Probert, Diagnosis and treatment of pyoderma gangrenosum. BMJ 2006 Jun 22;333 (7560):181-4. PubMed
17. Jorg R, Guido B, Anette B, Wolfgang T. Treatment recommendastions for pyoderma gangrenosum: An evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 2005 Aug;53(2):278-83. PubMed
18. Prystowsky JH, Kahn SN,Lazarus GS. Present status of pyoderma gangrenosum:review of 21 cases. Arch Dermatol 1989 Jan;125(1):57-64. PubMed
19. Work BA Jr. Pyoderma gangrenosum of the perineum. Obstet Gynecol 1980;55:126-8
20. Schwaitzberg SD, Bradshaw W, Williams TW. Pyoderma gangrenosum: a possible cause of wound necrosis. Arch Surg 1982 Mar;117(3):363-7. PubMed
21. Dean SJ, Nieber S, Hickerson WL. The use of cultured epithelial autograft in a patient with idiopathic pyoderma gangrenosum. Ann Plast Surg 1991 Feb;26(2):194-5. PubMed
22. Phillips TJ, Bigby M, Bercovitch L. Cultured allografts as an adjunct to the medical treatment of problematic leg ulcers. Arch Dermatol 1991 Jun;127(6):799-801. PubMed
23. Kubo K, Kuroyanagi YA. Study of cytokines released from fibroblasts in cultured dermal substitute. J Artif Organs 2005 Oct;29(10):845-9. PubMed